Key facts
- This page summarizes Steven Frank's Form 4 filing for PRECIGEN, INC. (PGEN).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Mar 2026, 16:23.
Steven Frank - 10 Mar 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Director
- Issuer ticker
- PGEN
- Reported as of
- 10 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2026, 16:23:34 UTC
- Prior SEC filing
- 03 Mar 2026
- Next SEC filing
- 16 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven Frank, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven Frank filed Form 4 for PRECIGEN, INC. (PGEN) on 12 Mar 2026.
Change
- Previous filing in this sequence was filed on 03 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001583886
Primary reporting owner
Frank Steven
- Relationship
- Director
- Address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
- Signature
- /s/ Steven Frank, by Donald P. Lehr, as attorney-in-fact
- Signature date
- 12 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
transaction
Common Stock
Award
- Transaction value
- Shares
- +14,245
- Change %
- +1.2%
- Price
- $3.51*
- Shares after
- 1,154,552
- Date
- 10 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +35,612
- Change %
- Price
- $0.000000*
- Shares after
- 35,612
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,612
- Exercise price
- Footnotes
- F2, F3
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Award
- Transaction value
- Shares
- +41,073
- Change %
- Price
- $0.000000*
- Shares after
- 41,073
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 41,073
- Exercise price
- $3.51
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were issued to the reporting person in lieu of an annual retainer of $50,000.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Footnote F3
The RSUs vest in full on March 10, 2027.